RDUS vs. TSLA

Last updated Apr 2, 2026

Compare and contrast key facts about Radius Health, Inc. (RDUS) and Tesla, Inc. (TSLA).

Performance

RDUS vs. TSLA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Radius Health, Inc. (RDUS) and Tesla, Inc. (TSLA). The values are adjusted to include any dividend payments, if applicable.

RDUS vs. TSLA - Yearly Performance Comparison

	2026 (YTD)
RDUS Radius Health, Inc.	0.00%
TSLA Tesla, Inc.	-7.26%

Fundamentals

Market Cap RDUS : $861.00M TSLA : $1.35T
EPS RDUS : -$3.04 TSLA : $1.08
PS Ratio RDUS : 0.42 TSLA : 14.18
Total Revenue (TTM) RDUS : $2.03B TSLA : $94.83B
Gross Profit (TTM) RDUS : $110.45M TSLA : $17.09B
EBITDA (TTM) RDUS : $11.40M TSLA : $11.76B

Returns By Period

RDUS

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

TSLA

• 1D: 2.56%
• 1M: -5.47%
• YTD: -15.22%
• 6M: -17.02%
• 1Y: 42.02%
• 3Y*: 22.49%
• 5Y*: 11.57%
• 10Y*: 37.45%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

RDUS vs. TSLA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TSLA

TSLA Risk / Return Rank: 68
TSLA Sharpe Ratio Rank: 67
TSLA Sortino Ratio Rank: 65
TSLA Omega Ratio Rank: 62
TSLA Calmar Ratio Rank: 73
TSLA Martin Ratio Rank: 73

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RDUS vs. TSLA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Radius Health, Inc. (RDUS) and Tesla, Inc. (TSLA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	RDUS	TSLA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	0.76	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.20	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.64	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.72	—

Dividends

RDUS vs. TSLA - Dividend Comparison

Neither RDUS nor TSLA has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

RDUS vs. TSLA - Drawdown Comparison

The maximum RDUS drawdown since its inception was 0.00%, smaller than the maximum TSLA drawdown of -73.63%. Use the drawdown chart below to compare losses from any high point for RDUS and TSLA.

Drawdown Indicators

	RDUS	TSLA	Difference
Max Drawdown Largest peak-to-trough decline	0.00%	-73.63%	+73.63%
Max Drawdown (1Y) Largest decline over 1 year	—	-27.48%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-73.63%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-73.63%	—
Current Drawdown Current decline from peak	0.00%	-22.17%	+22.17%
Average Drawdown Average peak-to-trough decline	0.00%	-22.77%	+22.77%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	11.30%	—

Volatility

Volatility by Period

	RDUS	TSLA	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	11.32%	—
Volatility (6M) Calculated over the trailing 6-month period	—	29.84%	—
Volatility (1Y) Calculated over the trailing 1-year period	0.00%	55.50%	-55.50%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	0.00%	59.08%	-59.08%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	0.00%	59.02%	-59.02%

Financials

RDUS vs. TSLA - Profitability Comparison

The chart below illustrates the profitability comparison between Radius Health, Inc. and Tesla, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

RDUS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Radius Health, Inc. reported a gross profit of 49.55M and revenue of 726.99M. Therefore, the gross margin over that period was 6.8%.

TSLA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Tesla, Inc. reported a gross profit of 5.01B and revenue of 24.90B. Therefore, the gross margin over that period was 20.1%.

RDUS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Radius Health, Inc. reported an operating income of -7.20M and revenue of 726.99M, resulting in an operating margin of -1.0%.

TSLA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Tesla, Inc. reported an operating income of 1.41B and revenue of 24.90B, resulting in an operating margin of 5.7%.

RDUS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Radius Health, Inc. reported a net income of -16.96M and revenue of 726.99M, resulting in a net margin of -2.3%.

TSLA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Tesla, Inc. reported a net income of 840.00M and revenue of 24.90B, resulting in a net margin of 3.4%.